Literature DB >> 19490057

Lipid-mediated inflammation and degeneration of bioprosthetic heart valves.

R Shetty1, P Pibarot, A Audet, R Janvier, F Dagenais, J Perron, C Couture, P Voisine, J P Després, P Mathieu.   

Abstract

BACKGROUND: The durability of bioprosthetic valves is limited by structural valve degeneration (SVD) leading to bioprostheses (BPs) stenosis or regurgitation. We hypothesized that a lipid-mediated inflammatory mechanism is involved in the SVD of BPs.
MATERIAL AND METHODS: Eighteen Freestyle stentless BP valves were explanted for SVD at a mean time of 5.9 +/- 3 years after implantation and were analysed by immunohistochemistry and transmission electron microscopy (TEM).
RESULTS: The mean age of the patients was 65 +/- 8 years and there were 11 male and seven female patients. Two of the 18 BPs had macroscopic calcification, whereas the other valves had minimal or no macroscopic calcification. Tears at the commissures leading to regurgitation was present in 16 BPs. Immunohistochemistry showed the presence of oxidized low-density lipoprotein (ox-LDL) and glycosaminoglycans in the fibrosa layer of 13 BPs. Areas with ox-LDL were infiltrated by macrophages (CD68(+)) co-expressing the scavenger receptor CD36 and metalloproteinase-9 (MMP-9). Zymogram showed the active form of MMP-9 within explanted BPs. EM studies revealed the presence of lipid-laden cells featuring foam cells and fragmented collagen. Nonimplanted control BPs obtained from the manufacturer (n = 4) had no evidence of lipid accumulation, inflammatory cell infiltration or expression of MMP9 within the leaflets.
CONCLUSIONS: These results support the concept that lipid-mediated inflammatory mechanisms may contribute to the SVD of BPs. These findings suggest that modification of atherosclerotic risk factors with the use of behavioural or pharmacological interventions could help to reduce the incidence of SVD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490057     DOI: 10.1111/j.1365-2362.2009.02132.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Valvular disease: The private life of tissue valves.

Authors:  Magdi H Yacoub; Ismail El-Hamamsy
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

2.  Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration.

Authors:  Mario Lopez-Moya; Pedro Melgar-Lesmes; Kumaran Kolandaivelu; Jose María de la Torre Hernández; Elazer R Edelman; Mercedes Balcells
Journal:  Biomacromolecules       Date:  2018-03-20       Impact factor: 6.988

Review 3.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  The susceptibility of bioprosthetic heart valve leaflets to oxidation.

Authors:  Abigail J Christian; Hongqiao Lin; Ivan S Alferiev; Jeanne M Connolly; Giovanni Ferrari; Stanley L Hazen; Harry Ischiropoulos; Robert J Levy
Journal:  Biomaterials       Date:  2013-12-18       Impact factor: 12.479

5.  Sirt1 inhibits resistin expression in aortic stenosis.

Authors:  Sophie Carter; Stéphanie Miard; Catherine Roy-Bellavance; Louise Boivin; Zhuo Li; Philippe Pibarot; Patrick Mathieu; Frédéric Picard
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

Review 6.  Stem cell therapy and tissue engineering for correction of congenital heart disease.

Authors:  Elisa Avolio; Massimo Caputo; Paolo Madeddu
Journal:  Front Cell Dev Biol       Date:  2015-06-30

7.  Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves.

Authors:  Olga Barbarash; Natalya Rutkovskaya; Oksana Hryachkova; Olga Gruzdeva; Evgenya Uchasova; Anastasia Ponasenko; Natalya Kondyukova; Yuri Odarenko; Leonid Barbarash
Journal:  Patient Prefer Adherence       Date:  2015-03-09       Impact factor: 2.711

8.  Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction.

Authors:  Suengwon Lee; Robert J Levy; Abigail J Christian; Stanley L Hazen; Nathan E Frick; Eric K Lai; Juan B Grau; Joseph E Bavaria; Giovanni Ferrari
Journal:  J Am Heart Assoc       Date:  2017-05-08       Impact factor: 5.501

9.  ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.

Authors:  Lionel Tastet; Romain Capoulade; Mylène Shen; Marie-Annick Clavel; Nancy Côté; Patrick Mathieu; Marie Arsenault; Élisabeth Bédard; Alexe Tremblay; Marilie Samson; Yohan Bossé; Jean G Dumesnil; Benoit J Arsenault; Jonathan Beaudoin; Mathieu Bernier; Jean-Pierre Després; Philippe Pibarot
Journal:  J Am Heart Assoc       Date:  2018-02-10       Impact factor: 5.501

Review 10.  Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts.

Authors:  Michele Carrabba; Paolo Madeddu
Journal:  Front Bioeng Biotechnol       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.